Lisinopril and Hydrochlorothiazide Tablets — Class II drug recall D-132-2013
Terminated recall by West-ward Pharmaceutical Corp., reported 2013-01-30, distributed nationwide. Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were
| Recall number | D-132-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | West-ward Pharmaceutical Corp., Eatontown, NJ, United States |
| Recall initiated | 2012-11-30 |
| Classified | 2013-01-18 |
| Reported by FDA | 2013-01-30 |
| Terminated | 2014-07-09 |
| Distributed | Nationwide (US) |
| Quantity | 43,478 bottles |
| Reason classes | specification failure |
| NDC | 00143-1264-01, 00143-1264-10 |
| Lot numbers | 09/15, 10/15, 69392A, 69393A, 69394A, 69395A, 69396A, 69397A, 69495A, 69496A, 69497A, 69498A, 69524A, 69525A |
Product
Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.
Reason for recall
Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-132-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.